Corcept Therapeutics
(NASDAQ:CORT)
$25.06
0[0.00%]
Last update: 4:00PM Get Real Time Here
Q1 2024 Earnings were released on Wed May 1st, after the market close
The most recent conference call was at 17:00 PM, 2 days ago Click to view past webcast
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Corcept Therapeutics Stock (NASDAQ:CORT), Quotes and News Summary

Corcept Therapeutics Stock (NASDAQ: CORT) stock price, news, charts, stock research, profile.

Open$25.060
Close-
Volume / Avg.304.374K / 1.102M
Day Range23.110 - 25.220
52 Wk Range20.840 - 34.275
Market Cap$2.609B
P/E Ratio26.681
Dividend Yield-
ExchangeNASDAQ
RSI
0
Short Interest
28.84%
Days to Cover25.23

Recent News

Mid-Cap Corcept Therapeutics Reveals Data From Hormonal Disorder Study, FDA Application Submission Expected This Quarter
Insights from Corcept Therapeutics' Phase 3 GRACE trial results for endogenous Cushing's syndrome. Discover rapid improvements in hypertension and hyperglycemia without adverse effects. Join us for the upcoming medical conference in June.
Vandana Singh
What's Going On With Stress Hormone Modulator-Focused Corcept Therapeutics' Stock Friday?
Findings of Corcept Therapeutics' CATALYST study on Cushing's syndrome & difficult-to-control type 2 diabetes.
Vandana Singh
Archer-Daniels-Midland, B. Riley Financial And Other Big Stocks Moving Lower In Monday's Pre-Market Session
U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 100 points on Monday. Shares of Archer-Daniels-Midland Company (NYSE: ADM) fell sharply in today’s pre-market trading after the company named Ismael Roig as Interim Chief Financial Officer.
Avi Kapoor
20%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Jan
1
Feb
1
Apr
2
May
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
3.3
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
CORT
NVO

FAQ

Q

How do I buy Corcept Therapeutics (CORT) stock?

A

You can purchase shares of Corcept Therapeutics (NASDAQ: CORT) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Corcept Therapeutics's (CORT) competitors?

A

Other companies in Corcept Therapeutics’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).

Q

What is the target price for Corcept Therapeutics (CORT) stock?

A

The latest price target for Corcept Therapeutics (NASDAQ: CORT) was reported by HC Wainwright & Co. on Thursday, May 2, 2024. The analyst firm set a price target for 40.00 expecting CORT to rise to within 12 months (a possible 59.62% upside). 15 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Corcept Therapeutics (CORT)?

A

The stock price for Corcept Therapeutics (NASDAQ: CORT) is $25.06 last updated May 2, 2024 at 4:00 PM EDT.

Q

Does Corcept Therapeutics (CORT) pay a dividend?

A

There are no upcoming dividends for Corcept Therapeutics.

Q

When is Corcept Therapeutics (NASDAQ:CORT) reporting earnings?

A

Corcept Therapeutics’s Q2 earnings are confirmed for Wednesday, July 31, 2024.

Q

Is Corcept Therapeutics (CORT) going to split?

A

There is no upcoming split for Corcept Therapeutics.

Q

What sector and industry does Corcept Therapeutics (CORT) operate in?

A

Corcept Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

People Also Watch